Concepedia

Author

Jasmine Zunic

Amplyx Pharmaceuticals (United States)

Also Known As

Jasmine Zunic

11

Publications

243

Citations

6

H-Index

20

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)
JZ

About

Jasmine Zunic is an author at Amplyx Pharmaceuticals (United States) specializing in natural sciences, biochemistry, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

43

2

Natural Sciences

2

2

132

3

Biochemistry

2

2

132

4

Chemical Biology

1

1

21

5

Immunology

1

1

22

Jasmine Zunic

×

5

Publications

220

Citations

5

H-Index

YearCitations

Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms

Kayo Sakaguchi, Mitchell Green, Nicholas Stock,

Archives of Biochemistry and Biophysics

2004

111

5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- <i>tert</i> -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 <i>H</i> -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor

Nicholas Stock, Gretchen Bain, Jasmine Zunic,

Journal of Medicinal Chemistry

2011

47

Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation

Daniel S. Lorrain, Gretchen Bain, Lucia Correa,

European Journal of Pharmacology

2010

22

5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor

Nicholas Stock, Christopher Baccei, Gretchen Bain,

Bioorganic & Medicinal Chemistry Letters

2009

21

Pharmacodynamics, pharmacokinetics and safety of <scp>GSK</scp>2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor

Gretchen Bain, Christopher D. King, Kevin Schaab,

British Journal of Clinical Pharmacology

2012

19

Page 1